These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3498 related articles for article (PubMed ID: 17713983)
1. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach. Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983 [TBL] [Abstract][Full Text] [Related]
2. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006. Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758 [TBL] [Abstract][Full Text] [Related]
3. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire. Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864 [TBL] [Abstract][Full Text] [Related]
4. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV. Palombi L; Marazzi MC; Voetberg A; Magid NA AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755 [TBL] [Abstract][Full Text] [Related]
6. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. Moodley D; Moodley J; Coovadia H; Gray G; McIntyre J; Hofmyer J; Nikodem C; Hall D; Gigliotti M; Robinson P; Boshoff L; Sullivan JL; J Infect Dis; 2003 Mar; 187(5):725-35. PubMed ID: 12599045 [TBL] [Abstract][Full Text] [Related]
7. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy. Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114 [TBL] [Abstract][Full Text] [Related]
8. Advances in the prevention of mother-to-child transmission of HIV-1 infection in resource-limited settings. Ekouevi DK; Tonwe-Gold B; Dabis F AIDS Read; 2005 Sep; 15(9):479-80, 487-93. PubMed ID: 16170877 [TBL] [Abstract][Full Text] [Related]
9. Impact of maternal HAART on the prevention of mother-to-child transmission of HIV: results of an 18-month follow-up study in Ouagadougou, Burkina Faso. Kouanda S; Tougri H; Cisse M; Simpore J; Pietra V; Doulougou B; Ouedraogo G; Ouedraogo CM; Soudre R; Sondo B AIDS Care; 2010 Jul; 22(7):843-50. PubMed ID: 20635248 [TBL] [Abstract][Full Text] [Related]
10. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial. ; de Vincenzi I Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718 [TBL] [Abstract][Full Text] [Related]
11. Low risk of nevirapine resistance mutations in the prevention of mother-to-child transmission of HIV-1: Agence Nationale de Recherches sur le SIDA Ditrame Plus, Abidjan, Cote d'Ivoire. Chaix ML; Ekouevi DK; Rouet F; Tonwe-Gold B; Viho I; Bequet L; Peytavin G; Toure H; Menan H; Leroy V; Dabis F; Rouzioux C; J Infect Dis; 2006 Feb; 193(4):482-7. PubMed ID: 16425126 [TBL] [Abstract][Full Text] [Related]
12. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Siegfried N; van der Merwe L; Brocklehurst P; Sint TT Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of the first district-wide programme for the prevention of mother-to-child transmission of HIV in South Africa. Coetzee D; Hilderbrand K; Boulle A; Draper B; Abdullah F; Goemaere E Bull World Health Organ; 2005 Jul; 83(7):489-94. PubMed ID: 16175822 [TBL] [Abstract][Full Text] [Related]
14. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update. Dao H; Mofenson LM; Ekpini R; Gilks CF; Barnhart M; Bolu O; Shaffer N Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S42-55. PubMed ID: 17825650 [TBL] [Abstract][Full Text] [Related]
15. Operational issues in preventing mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire, 1998-99. Msellati P; Hingst G; Kaba F; Viho I; Welffens-Ekra C; Dabis F Bull World Health Organ; 2001; 79(7):641-7. PubMed ID: 11477967 [TBL] [Abstract][Full Text] [Related]
16. Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana. Shapiro RL; Thior I; Gilbert PB; Lockman S; Wester C; Smeaton LM; Stevens L; Heymann SJ; Ndung'u T; Gaseitsiwe S; Novitsky V; Makhema J; Lagakos S; Essex M AIDS; 2006 Jun; 20(9):1281-8. PubMed ID: 16816557 [TBL] [Abstract][Full Text] [Related]
17. [Preventing the transmission of HIV-1 from mother to child in Africa in the year 2000]. Castetbon K; Leroy V; Spira R; Dabis F Sante; 2000; 10(2):103-13. PubMed ID: 10960807 [TBL] [Abstract][Full Text] [Related]
18. Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV. Chalermchockcharoenkit A; Culnane M; Chotpitayasunondh T; Vanprapa N; Leelawiwat W; Mock PA; Asavapiriyanont S; Teeraratkul A; McConnell MS; McNicholl JM; Tappero JW Clin Infect Dis; 2009 Jul; 49(2):299-305. PubMed ID: 19522656 [TBL] [Abstract][Full Text] [Related]
20. Increased infant human immunodeficiency virus-type one free survival at one year of age in sub-saharan Africa with maternal use of highly active antiretroviral therapy during breast-feeding. Marazzi MC; Nielsen-Saines K; Buonomo E; Scarcella P; Germano P; Majid NA; Zimba I; Ceffa S; Palombi L Pediatr Infect Dis J; 2009 Jun; 28(6):483-7. PubMed ID: 19483516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]